DR. JOHN HENRY HEINZERLING II M.D.
Prescription History 1306045752
Radiology - Radiation Oncology in Charlotte, NC
Medicare Part D Prescription History
Explore the verified Medicare Part D prescription history, volume metrics, and calculated drug costs for DR. JOHN HENRY HEINZERLING II M.D., an active Radiation Oncology specialist practicing in Charlotte, NC. Our medical registry currently tracks 3 unique pharmaceutical formulations prescribed by this provider, representing an estimated volume of 59 documented patient claims. Among these therapy options, the most frequently utilized medication is Tamsulosin Hcl, which accounts for 34 claims alone. Use the table below to sort by claims, cost, or utilization compared with the state average; select any medication for its full profile.
| Medication | Prescriptions (2024)Rx (2024) | Avg Cost per FillCost / Fill | Vs. Other NC PrescribersVs. NC Avg |
|---|---|---|---|
| Tamsulosin Hcl | 34 | $5.20▼ below NC avg | ▼ Less than typical |
About Tamsulosin Hcl: Tamsulosin is used by men to treat the symptoms of an enlarged prostate (benign prostatic hyperplasia-BPH). Show more ▾ It does not shrink the prostate, but it works by relaxing the muscles in the prostate and the bladder. This helps to relieve symptoms of BPH such as difficulty in beginning the flow of urine, weak stream, and the need to urinate often or urgently (including during the middle of the night). Tamsulosin belongs to a class of drugs known as alpha blockers. Do not use this medication to treat high blood pressure. A sulfonamide derivative and adrenergic alpha-1 receptor antagonist that is used to relieve symptoms of urinary obstruction caused by BENIGN PROSTATIC HYPERPLASIA. In 2024, this provider wrote 34 Medicare prescriptions for Tamsulosin Hcl, about a third of the volume of the typical North Carolina prescriber of this medication (83.4). Medicare paid an average of $5.20 per fill, versus $13.02 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average NC prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the NC average for this medication. 50 30-Day Fills standardized to 30-day supplies 1,453 Days of Medication total across all patients in 2024 | |||
| Lidocaine Hcl ViscousLidocaine Hcl | 13 | $18.90 | ▼ Less than typical |
About Lidocaine Hcl Viscous: See also Warning section. Show more ▾ Viscous lidocaine is used to relieve pain and discomfort from a sore throat/mouth. It is also used to numb the lining of the mouth and throat before certain medical/dental procedures (such as dental impressions). This numbing helps prevent the urge to close the throat (gag reflex), which might make the procedure more difficult. Lidocaine belongs to a class of drugs known as local anesthetics. A local anesthetic and cardiac depressant used as an antiarrhythmia agent. Its actions are more intense and its effects more prolonged than those of PROCAINE but its duration of action is shorter than that of BUPIVACAINE or PRILOCAINE. In 2024, this provider wrote 13 Medicare prescriptions for Lidocaine Hcl Viscous, about 69% of the volume of the typical North Carolina prescriber of this medication (18.8). Medicare paid an average of $18.90 per fill, versus $14.82 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average NC prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 13.4 30-Day Fills standardized to 30-day supplies 213 Days of Medication total across all patients in 2024 | |||
| Silver Sulfadiazine | 12 | $14.06▼ below NC avg | ▼ Less than typical |
About Silver Sulfadiazine: This medication is used with other treatments to help prevent and treat wound infections in patients with serious burns. Show more ▾ Silver sulfadiazine works by stopping the growth of bacteria that may infect an open wound. This helps to decrease the risk of the bacteria spreading to surrounding skin, or to the blood where it can cause a serious blood infection (sepsis). Silver sulfadiazine belongs to a class of drugs known as sulfa antibiotics. Silver sulfadiazine must not be used on premature babies or on newborns during the first 2 months of life because of the risk of serious side effects. Antibacterial used topically in burn therapy. In 2024, this provider wrote 12 Medicare prescriptions for Silver Sulfadiazine, about half the volume of the typical North Carolina prescriber of this medication (20). Medicare paid an average of $14.06 per fill, versus $14.57 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average NC prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the NC average for this medication. 12 30-Day Fills standardized to 30-day supplies 329 Days of Medication total across all patients in 2024 | |||
About this data. The prescription history for DR. JOHN HENRY HEINZERLING II M.D. is compiled from the Centers for Medicare & Medicaid Services (CMS) Medicare Part D Prescriber Public Use File for calendar year 2024, the most recent federal release. Figures cover prescriptions filled for Medicare Part D beneficiaries only; prescriptions under private insurance, Medicaid, or self-pay plans are not included. Because prescribing decisions are generally consistent across coverage types, this record offers a useful view of the overall Radiation Oncology prescribing approach at this Charlotte, NC practice.
Reading the costs. Drug costs are gross amounts paid to pharmacies under Part D, including both plan and beneficiary payments. They are not the price a patient pays at the pharmacy counter. Medications with fewer than 11 claims are excluded from the federal source data, and state comparisons use the average among NC prescribers of the same medication and form, shown only when at least five prescribers contribute. Always confirm current medications and costs directly with the provider and your plan.
About the medication summaries. Drug use descriptions come from the CMS Medicare Part D Drug Spending Dashboard (2024), and substance definitions from Medical Subject Headings (MeSH) 2026, U.S. National Library of Medicine. They are summaries that do not contain all possible information about a medication and are not individual medical advice. Ask a health care professional about any medication and your specific health needs.
